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Sudden cardiac death (SCD) remains a leading cause of death in the United States and accounts for
∼460,000 deaths annually (Zheng et al., 2001; Roger et al., 2012). Importantly, there is increasing
evidence that metabolic syndrome, a disease process defined by a clustering of pathologies (obesity,
diabetes, dyslipidemia and inflammation), is a significant contributor to the risk for SCD (Yang
et al., 2015). Therefore, it is important to understand the intertwined complexity of metabolic
disorders and how cardiomyocytes respond to the associated electrical and structural perturbations.
In order to develop novel and effective strategies to prevent SCD in people with metabolic disorders
there is a need to identify metabolic risk factors. In this Research Topic we present a series of articles
from experts in various aspects of metabolic disorders and heart disease. Our hope is that the
research ideas shared in these articles will create new discussions around existing gaps in knowledge
and help initiate future metabolic studies in cardiac health and disease.
The Research Topic starts with a review article from van Opbergen et al. that describes an
important role for pathological mitochondrial function in the development of arrhythmogenic
cardiomyopathy (ACM), an electrical disease mechanism that increases the risk for SCD,
particularly in young people and athletes (Corrado et al., 2017). While impaired mitochondrial
function has been widely studied in the context of arrhythmogenesis, how this occurs in ACM
remains unclear. The authors highlight defective mitochondrial ATP production and altered redox
regulation as key mechanisms that may increase vulnerability to ACM. Thus, ACM studies that
incorporate mitochondrial biology are emphasized with the expectation for novel mechanistic
insights for the development of targeted therapies in people living with ACM.
A similar perspective to van Opbergen et al. is provided by Snyder et al.. In their review
article, they discuss a critical role for cardiac metabolism, particularly as it relates to the electrical
and structural properties that define normal cardiac sinus rhythm. Furthermore, they raise the
possibility that a metabolism-based therapeutic strategy may be a promising approach in people
with heart disease. The review by Xu et al. aims to emphasize the critical link between impaired
cardiac metabolism and SCD. They elegantly guide the reader through the nicotinamide adenine
dinucleotide (NAD+ ) pathway and how its impaired function may contribute to SCD. The authors
conclude with a convincing argument in favor of NAD+ -boosting therapies in people living with
cardiovascular disease.
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In a continuing dialogue about ATP production, myocardial
energy metabolism and cardiac contractility, the review by
Greenwell et al. provides a comprehensive perspective into
distinct metabolic triggers that underlie acquired or genetic
cardiomyopathies. Taken together, these reviews offer an
intriguing prospect of how existing, as well as emerging
data, suggest that metabolic pathways are spatially and
temporally intertwined at multiple levels. Therefore, future
studies that consider potential outcomes due to multiple or
compartmentalized pathologies are likely to be informative and
shift current paradigms.
Impaired beat-to-beat Ca2+ dynamics predispose to fatal
arrhythmias, leading to heart failure (HF) (Balke and Shorofsky,
1998; Mora et al., 2019), and two research articles on this
topic provide crucial evidence for reduced expression of cardiac
bridging integrator 1 (cBIN1), a membrane curvature protein
that generates Ca2+ microdomains at the myocyte t-tubular
system. First, Hitzeman et al. demonstrated a novel finding that
a high cBIN1 score (or CS) is an important marker of pathologic
cardiac remodeling and predicts a 1-year risk of cardiovascular
events in ambulatory people who have HF with preserved
ejection fraction. This conclusion is also supported by the
findings of Li et al.. They revealed that, in a mouse model of preexisting HF, exogenous cBIN1 limited HF progression, improved
cardiac function, and increased survival by normalizing ttubule Ca handling microdomains. These findings are clinically
relevant and further underscore the importance of CS testing
with the ability to detect smaller changes in t-tubule cBIN1
levels in pre-HF, especially those cases that are associated with
metabolic disorder.
Two articles in this Research Topic focused on circadian
mechanisms, arrhythmias, and risk for SCD. Bernardi et al.
explores how the circadian-dependent modulation of metabolic
and environmental cues, lead to altered hormonal and autonomic
signaling and contribute to arrhythmias. Schroder et al.
investigated how the disruption of the cardiac circadian clock
by inducing the deletion of Bmal1, the core circadian clock
transcription factor, impacts cardiac function in a knock-in
mouse (Scn5a+/1KPQ ) model of long QT syndrome type 3
(LQT3). The authors demonstrated that inducing the deletion
of Bmal1 in cardiomyocytes decreased the expression of
several different cardiac ion channel mRNA transcripts and
increased the QT interval at slow heart rates in wild-type and
Scn5a+/1KPQ mice.
The relationship between the metabolic syndrome and
acquired arrhythmias was also studied by Yang et al. who
investigated the effects of low magnesium (or hypomagnesemia)
on electrocardiographic (ECG) parameters. Hypomagnesemia is

acquired in people with metabolic disorders (Guerrero-Romero
and Rodríguez-Morán, 2002), and here Yang et al. shows that
people with hypomagnesemia displayed significant ECG changes,
including an increase in the heart rate corrected QT interval
and P wave duration, consistent with both impaired atrial and
ventricular repolarization. Overall, these findings highlight how
individual metabolic mechanisms may independently modify
cardiac function.
The article by Espinoza et al. highlights the interplay between
cardiometabolic function, parasympathetic (or vagal) motor
output and the effects on cardiac function. Specifically, the
authors focus their discussion on how vagal motor output may
modulate metabolic cues and affect cardiac function. The authors
state that vagal brainstem circuits provide a unique integrative
mechanism that regulates and responds to metabolic cues to
impact cardiac function.
Impaired thyroid function and the metabolic syndrome
are interlinked endocrine disorders with significant morbidity
and mortality in people worldwide. Additionally, thyroid
hormone (TH) plays an important role in modulating cardiac
electrophysiological properties. The article by Yamakawa et al.
discusses the current knowledge on TH action on the
cardiovascular system, relevant clinical and hemodynamic
laboratory findings, and the therapeutic management for people
with hyper- or hypo-thyroid heart disease. They also discuss
cardiovascular medications that can disrupt normal thyroid
function, including amiodarone-induced thyroid toxicity.
Overall, this Research Topic continues the discussion for
how perturbations in several distinct metabolic mechanisms can
have significant implications for cardiac function. Specifically,
the articles published in this topic highlight how normal and
impaired metabolic cues can impact electrical, structural, neural,
and hormonal modulation of cardiac function. Expanding
research that explores how metabolic disorders impact and
contribute to heart disease will advance the field in ways that
improve therapeutic options, better the quality of life for people
living with heart disease and reduce the risk for SCD.
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